Stereochemistry and functions of the new cysteinyl‐resolvin, 4S , 5R‐RCTR1 , in efferocytosis and erythrophagocytosis of human senescent erythrocytes
American Journal of Hematology · 2023-07 · 98 (7) · 1000-1016
DOI: 10.1002/ajh.26932 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 04.05.2023. Verfasst von Robert Nshimiyimana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospi…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Lymphohistiocytosis, Hemophagocytic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Specialized pro‐resolving lipid mediators play key functions in the resolution of the acute inflammatory response. Herein, we elucidate the stereochemical structure of the new 4S,5R‐RCTR1, a cysteinyl‐resolvin, recently uncovered in human leukocytes incubated with a 4S,5S‐epoxy‐resolvin intermediate, using liquid chromatography–tandem mass spectrometry (LC–MS/MS) and ultra‐violet (UV) spectrophotometry. With this approach, the physical properties of the new mediator prepared by total organic synthesis were matched to enzymatically produced biogenic material. In addition, we confirmed the potent biological actions of 4S,5R‐RCTR1 with human M2‐like macrophage phagocytosis of live bacteria, efferocytosis of apoptotic neutrophils, and erythrophagocytosis of senescent human red blood cells in a concentration‐dependent manner from 0.1 to 10 nM. Taken together, these results establish the complete stereochemistry of 4S,5R‐RCTR1 as 5R‐glutathionyl‐4S,17S‐dihydroxy‐6E,8E,10Z,13Z,15E,19Z‐docosahexaenoic acid and give evidence of its novel bioactivities in human phagocyte responses. Moreover, they confirm and extend the stereoselective functions of the 4S,5R‐RCTR1 with isolated human phagocytes of interest in the resolution of inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Cell Biology, Rowan University-School of Medicine, Stratford, New Jersey, USA.
- Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska institute, Stockholm, Sweden.
ORCID-Profile: Robert Nshimiyimana, Stephania Libreros, Mélissa Simard, Nan Chiang, Ana R Rodriguez, Bernd W Spur, Jesper Z Haeggström, Charles N Serhan
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Nshimiyimana, R., Libreros, S., Simard, M., Chiang, N., Rodriguez, A. R., Spur, B. W., Haeggström, J. Z., & Serhan, C. N. (2023). Stereochemistry and functions of the new cysteinyl‐resolvin, 4S , 5R‐RCTR1 , in efferocytosis and erythrophagocytosis of human senescent erythrocytes. American Journal of Hematology, 98(7), 1000-1016. https://doi.org/10.1002/ajh.26932
Vancouver
Nshimiyimana R, Libreros S, Simard M, Chiang N, Rodriguez AR, Spur BW, et al. Stereochemistry and functions of the new cysteinyl‐resolvin, 4S , 5R‐RCTR1 , in efferocytosis and erythrophagocytosis of human senescent erythrocytes. American Journal of Hematology. 2023;98(7):1000-1016. doi:10.1002/ajh.26932
BibTeX
@article{Nshimiyimana2023,
author = {Nshimiyimana, Robert and Libreros, Stephania and Simard, Mélissa and Chiang, Nan and Rodriguez, Ana R and Spur, Bernd W and Haeggström, Jesper Z and Serhan, Charles N},
title = {Stereochemistry and functions of the new cysteinyl‐resolvin, 4S , 5R‐RCTR1 , in efferocytosis and erythrophagocytosis of human senescent erythrocytes},
journal = {American Journal of Hematology},
year = {2023},
volume = {98},
number = {7},
pages = {1000--1016},
doi = {10.1002/ajh.26932}
}
EUVIMED